Conceptus(R) Announces 10-Year Commercial Data for Essure(R) at 40th AAGL Global Congress of Minimally Invasive Gynecology - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Get our newsletter
Order Prints
November 8, 2011
Share
Share
Post
Email

Conceptus(R) Announces 10-Year Commercial Data for Essure(R) at 40th AAGL Global Congress of Minimally Invasive Gynecology

Copyright:  2011 GlobeNewswire, Inc.
Source:  GlobeNewswire
Wordcount:  950

MOUNTAIN VIEW, Calif., Nov. 8, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc.(Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method available*, today released a new data report on Essure's 10-year commercial success at the 40th AAGL Global Congress of Minimally Invasive Gynecology in Hollywood, Florida, November 7-10, 2011.

This 10-year global study explores the commercial use of Essure by approximately 500,000 women. The new data tracks closely with Essure's clinical effectiveness rate of 99.8% based on four years of follow-up with zero pregnancies reported in clinical trials. 

"As the pioneer and market leader of hysteroscopic sterilization, we are pleased to be celebrating this milestone achievement for the Essure procedure at AAGL this year," said Mark Sieczkarek, president and chief executive officer of Conceptus. "Besides being the most effective form of permanent birth control, Essure is also the leading office-based method of female sterilization and offers patients a minimally-invasive procedure that takes less than 10 minutes with no incisions, no hormones and a short recovery period."

"Most patients have heard about tubal ligation or vasectomy. However, now that Essure has a decade of successfully proven commercial experience, it is time that more OB/GYNs and other healthcare professionals start recommending this safer, more convenient alternative to appropriate patients," said Barbara Levy, M.D., medical director for Conceptus.  

The AAGL Global Congress will feature more than 20 ground-breaking scientific communications on the Essure system from presenters around the world. Several of the presentations will favorably compare Essure to other forms of sterilization including laparoscopic tubal ligation, vasectomy, and a competitive hysteroscopic sterilization procedure. Among the presentations are:

  • Reported pregnancies after Essure® Hysteroscopic Sterilization: A Retrospective Analysis of Pregnancy Reports Worldwide: 2001-2010; Levy BS, Munro MG, Veersema S, Vleugels M.  Women's Health, Franciscan Health Systems, Federal Way, Washington; Department of Obstetrics & Gynecology, UCLA David Giffen School of Medicine, Los Angeles, CA; Department of Obstetrics & Gynecology, St. Antonius Hospital, Nieuwegein, Netherlands; Department of Obstetrics & Gynecology, Riverland Hospital Tiel, Tiel, Netherlands
  • A Comparative Study between Hysteroscopic (Essure) Versus Laparoscopic Sterilization: Patient Satisfaction; Perez C, Lopez G, Guillen C, Alvarez C, Jimenez JS, Munoz JL, Lorenzo E.  Department of Obstetrics & Gynecology, Madrid, Spain
  • Essure Versus Vasectomy: An analysis of Success, Complications, Pain, and Pregnancy; Smith KS, Gephart LF, Cooper J, Obstetrics & Gynecology, Howard University Hospital, Washington, DC
  •  Hysteroscopic Placement of the Essure Device in the Office-Setting; Levie M, Chudnoff S, Palmer S, To J. Montefiore Medical Center, Bronx, NY
  •  Impact of Experience on Essure Placement Rates; Levie M, Chudnoff S. Obstetrics & Gynecology and Women's Health, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY

As a long-standing contributor to AAGL, Conceptus will be an active participant in several conference activities that focus on the continuing education of residents and fellows. For example, the Company will participate in an office-based CME post-graduate course. At the Conceptus exhibitor booth, company representatives will celebrate the new 10-year commercial data results with an historical timeline of key Essure milestones, as well as provide visitors an opportunity to train on the Company's state-of-the-art EssureSim™ simulator that replicates the Essure procedure. The booth will also feature details on the Essurance™ Promise Program (Patient Reliance Warranty), the Essure FlexPay™ Plan, and Patient Education Systems digital program that facilitates patient awareness and education about office-based gynecological procedures. 

"This year's AAGL meeting marks the turning point for Essure after a decade of clinical excellence. We are positioned to expand awareness about Essure to both women who are done having children and the physicians who treat them," said Sieczkarek. "We share the vision with the members of AAGL to provide optimal patient care through minimally-invasive gynecology, and thank them for advancing Essure as a safe and effective office-based  method of permanent birth control."

About the Essure® Procedure

The Essure procedure, FDA approved since 2002, is the first permanent birth control method that can be performed in the comfort of a physician's office in less than 10 minutes (average hysteroscopic time) without hormones, cutting, burning or the risks associated with general anesthesia or tubal ligation. Soft, flexible inserts are placed in a woman's fallopian tubes through the cervix without incisions. Over the next three months, the body forms a natural barrier around and through the inserts to prevent sperm from reaching the egg. Three months after the Essure procedure, a doctor is able to perform an Essure Confirmation Test to confirm that the inserts are properly placed and that the fallopian tubes are fully blocked, allowing the patient to rely upon Essure for permanent birth control.

The Essure procedure is covered by most insurance plans, and when it is performed in a doctor's office the cost to the patient may be as low as a simple co-pay. Essure has been proven and trusted by physicians since 2002, with more than 570,000 women worldwide having undergone the Essure procedure.

About Conceptus, Inc.

Conceptus, Inc. is a leader in the design, development and marketing of innovative solutions in women's healthcare. The Company manufactures and markets the Essure procedure. The Essure procedure is available in the United States, Europe, Australia, New Zealand, Canada, Mexico, Central and South America and the Middle East. The Company also promotes the GYNECARE THERMACHOICE® Uterine Balloon Therapy System by ETHICON™ Women's Health & Urology, a division of Ethicon, Inc., in U.S. OB/GYN physician offices.

Please visit www.essure.com for more information on the Essure procedure. Patients may call the Essure Information Center at 1-877-ESSURE-1 with questions or to find a physician in their area.

© 2011 Conceptus, Inc.—All rights reserved. Conceptus and Essure are trademarks or registered trademarks of Conceptus, Inc.

*Based on 4 years of clinical data

CC-2951  7NOV11F

CONTACT: Investor Relations and Public Relations Contact:          Cindy Klimstra          (650) 962-4032          cindy_klimstra@conceptus.com

Conceptus, Inc. Logo

Source: Conceptus, Inc.

Older

Sybase Extends Innovation in Capital Markets Analytics by Integrating Sybase RAP With the Statistical Programming Language R

Advisor News

  • The Gen Z money paradox
  • NAIFA applauds final SECURE 2.0 regulations
  • What will Democrats in Congress do about healthcare and retirement?
  • Election results cloud retirement legislation outlook, experts say
  • Planning for the missing chapter
More Advisor News

Annuity News

  • AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
  • Boomers want retirement protection, but their actions don’t match their mindset
  • NAIC task force to address LTC riders
  • ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
  • Jackson Launches Direct-to-Consumer Annuity Offering
More Annuity News

Health/Employee Benefits News

  • 3 ways Crowley can make Healthcare more affordable in Wisconsin 3 ways to make healthcare more affordable in Wisconsin | Coleman Drake (Copy)
  • Vermont public schools expect the lowest health insurance increase in years. For districts, it’s only a small relief.
  • Vt. public schools expect the lowest health insurance increase in years
  • Samantha Wildow: Mercy Health warns thousands of Medical Mutual of Ohio patients may go out-of-network in 2027
  • Reports Outline Managed Care Study Results from Harvard University (Inpatient-Only List Removals Shifted Procedures To The Outpatient Setting And Reduced Medicare Spending): Managed Care
More Health/Employee Benefits News

Life Insurance News

  • AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
  • U-Haul Holding Company to Participate in Deutsche Bank Conference
  • NAIC task force to address LTC riders
  • Protective names Kurt Meyers Chief Legal Officer and Fernando Levy Chief Digital & AI Officer
  • Best’s Commentary: Shanghai Cross-Border Investment Pilot Unlocks Overseas Growth Potential of China Non-Life Companies
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • OpenRoad Insurance Data Shows 40% of Collector Vehicles Are Model Year 1980 or Newer
  • Insurvoice Lets Independent Insurance Agency Owners Analyze Every Customer Call in ChatGPT or Claude
  • Spectrum Weather & Specialty Insurance Celebrates 15 Years and Welcomes the Next Generation
  • Royal Neighbors of America® Increases Service Capacity
  • Benefits Studio Launches to Fill the Missing Middle of Benefits Navigation at $49/mo
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.